267 related articles for article (PubMed ID: 33673277)
1. Biological Pathways Associated with Neuroprogression in Bipolar Disorder.
Wollenhaupt-Aguiar B; Kapczinski F; Pfaffenseller B
Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33673277
[TBL] [Abstract][Full Text] [Related]
2. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J
Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314
[TBL] [Abstract][Full Text] [Related]
3. Staging and neuroprogression in bipolar disorder.
Fries GR; Pfaffenseller B; Stertz L; Paz AV; Dargél AA; Kunz M; Kapczinski F
Curr Psychiatry Rep; 2012 Dec; 14(6):667-75. PubMed ID: 23090632
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.
Calkin CV
Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713
[TBL] [Abstract][Full Text] [Related]
5. Areas of controversy in neuroprogression in bipolar disorder.
Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F
Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559
[TBL] [Abstract][Full Text] [Related]
6. Staging and neuroprogression in bipolar disorder: a systematic review of the literature.
Gama CS; Kunz M; Magalhães PV; Kapczinski F
Braz J Psychiatry; 2013 Mar; 35(1):70-4. PubMed ID: 23567604
[TBL] [Abstract][Full Text] [Related]
7. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
[TBL] [Abstract][Full Text] [Related]
8. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.
Rizzo LB; Costa LG; Mansur RB; Swardfager W; Belangero SI; Grassi-Oliveira R; McIntyre RS; Bauer ME; Brietzke E
Neurosci Biobehav Rev; 2014 May; 42():157-69. PubMed ID: 24548785
[TBL] [Abstract][Full Text] [Related]
9. Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder.
Calkin C; McClelland C; Cairns K; Kamintsky L; Friedman A
Front Psychiatry; 2021; 12():636174. PubMed ID: 34113269
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review.
Grewal S; McKinlay S; Kapczinski F; Pfaffenseller B; Wollenhaupt-Aguiar B
Aust N Z J Psychiatry; 2023 Mar; 57(3):328-343. PubMed ID: 35403455
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
[TBL] [Abstract][Full Text] [Related]
12. Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder.
Cyrino LAR; Delwing-de Lima D; Ullmann OM; Maia TP
Front Behav Neurosci; 2021; 15():609487. PubMed ID: 33732117
[TBL] [Abstract][Full Text] [Related]
13. Neuroprogression and illness trajectories in bipolar disorder.
Kapczinski NS; Mwangi B; Cassidy RM; Librenza-Garcia D; Bermudez MB; Kauer-Sant'anna M; Kapczinski F; Passos IC
Expert Rev Neurother; 2017 Mar; 17(3):277-285. PubMed ID: 27659841
[TBL] [Abstract][Full Text] [Related]
14. Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.
Cardoso T; Bauer IE; Meyer TD; Kapczinski F; Soares JC
Curr Psychiatry Rep; 2015 Sep; 17(9):75. PubMed ID: 26257147
[TBL] [Abstract][Full Text] [Related]
15. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.
Cuperfain AB; Kennedy JL; Gonçalves VF
Neurosci Biobehav Rev; 2020 Apr; 111():125-134. PubMed ID: 31978440
[TBL] [Abstract][Full Text] [Related]
16. Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature.
Serafini G; Pardini M; Monacelli F; Orso B; Girtler N; Brugnolo A; Amore M; Nobili F; Team On Dementia Of The Irccs Ospedale Policlinico San Martino DM
Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33672401
[TBL] [Abstract][Full Text] [Related]
17. Staging in bipolar disorder: from theoretical framework to clinical utility.
Berk M; Post R; Ratheesh A; Gliddon E; Singh A; Vieta E; Carvalho AF; Ashton MM; Berk L; Cotton SM; McGorry PD; Fernandes BS; Yatham LN; Dodd S
World Psychiatry; 2017 Oct; 16(3):236-244. PubMed ID: 28941093
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and staging of bipolar disorder: a systematic review.
Roda Â; Chendo I; Kunz M
Trends Psychiatry Psychother; 2015; 37(1):3-11. PubMed ID: 25860561
[TBL] [Abstract][Full Text] [Related]
19. Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.
Rosenblat JD; McIntyre RS
Brain Sci; 2017 Oct; 7(11):. PubMed ID: 29084144
[TBL] [Abstract][Full Text] [Related]
20. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders.
Morris G; Puri BK; Walker AJ; Maes M; Carvalho AF; Bortolasci CC; Walder K; Berk M
Neurosci Biobehav Rev; 2019 Dec; 107():862-882. PubMed ID: 31545987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
